The goal: to evaluate the role of high dose ara-c plus idarubicin and mitoxantrone
consolidation followed by maintenance in the setting of high total cumulative anthracyclines
Drug: high dose ARA-C
Drug: standard dose ARA-C
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01587430
Ages eligible for Study
15 Years to 60 Years
Genders eligible for Study
Accepts Healthy Volunteers
de novo acute myeloid leukemia - age 15-60
secondary acute myeloid leukemia
acute myeloid leukemia from myelodysplastic syndrome
Ph+ acute myeloid leukemia
All locations for NCT01587430
Russian Federation (1)
National Research Center for Hematology
Moscow, Russian Federation, 125167
View full eligibility
Tris trial is registered with FDA with number: NCT01587430. The sponsor of the trial is National Research Center for Hematology, Russia and it is looking for 245 volunteers for the current phase.
Official trial title: Multicenter Randomised Clinical Trial in Acute Myeloid Leukemia Treatment Based on Three Anthracyclines, Comparing Two Types of Consolidation With Different ARA-C Doses Followed by One Year Maintenance
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.